What is Teriparatide used for?
Teriparatide is most commonly used for severe osteoporosis under endocrine care; stress-fracture recovery (off-label); older adults with high fracture risk. A bone-building drug. A parathyroid-hormone fragment (PTH 1-34), FDA-approved as Forteo for severe osteoporosis. Anabolic for bone, the opposite of bisphosphonates. Human evidence for Teriparatide is limited, so these are the goals people pursue with it, not guaranteed outcomes.
What people use Teriparatide for
- Severe osteoporosis under endocrine care
- Stress-fracture recovery (off-label)
- Older adults with high fracture risk
References
- Effect of Teriparatide on the risk of fractures in postmenopausal women with osteoporosis — Neer RM et al., NEJM, 2001
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial — Kendler DL, Marin F, Geusens P, et al. — The Lancet, 2018
- FORTEO (teriparatide) injection — FDA Prescribing Information — FDA / DailyMed (Eli Lilly and Company)
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Teriparatide
Last updated 2026-06-15.